N-(2-benzylphenyl)-2-chloroacetamide

We are N-(2-benzylphenyl)-2-chloroacetamide CAS:21535-43-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(2-benzylphenyl)-2-chloroacetamide
CAS.NO:21535-43-3
Synonyms:N-(2-benzylphenyl)-2-chloroacetamide
2-Chloro-N-[2-(benzyl)phenyl]acetamide
N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide
 
Physical and Chemical Properties:
Density 1.217g/cm3
Boiling Point 443.2ºC at 760 mmHg
Molecular Formula C15H14ClNO
Molecular Weight 259.73100
Flash Point 221.8ºC
Vapour Pressure 4.73E-08mmHg at 25°C
Index of Refraction 1.617
 
Specification:
Appearance:Light brown powder
Assay:≥98.0%
Loss on drying:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Epinastine(CAS:80012-43-7)、Epinastine hydrobromide(CAS:127786-29-2) and Epinastine hydrochloride(CAS:108929-04-0).

N-(2-benzylphenyl)-2-chloroacetamide


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2-Ethyl-3-methoxypyrazine Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.4-Chlorobutyl 3,4-dimethoxybenzoate At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.1-IODO-4,4,4-TRIFLUOROBUTANE CAS:461-17-6 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.

Related Products
Product Name
(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate View Details
4-Bromo-1,3-bis(trifluoromethyl)benzene View Details
3-Fluorophthalodinitrile View Details
3,5-Dimethylphenylboronic acid manufacturer 18-crown-6 manufacturer Tetraethylammonium bromide manufacturer Ethyl 5-aminobenzo[b]furan-2-carboxylate manufacturer 2,4,6-Tribromophenyl isothiocyanate manufacturer